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Introduction
Cirrhosis is the end result of chronic liver disease where persistent inflammation and stellate cell activation leads to collagen deposition, fibrosis, disruption of the intrahepatic venous flow and the development of portal hypertension [1] . Initially, the disease course may be asymptomatic, but if the insult persists, it may progress to decompensated cirrhosis with development of ascites, variceal bleeding and encephalopathy. However, at any moment during the disease course a precipitating event can trigger rapid deterioration of liver function and organ failure, referred to as acute-on-chronic liver failure (ACLF) associated with high inhospital mortality rates, approaching 70% [2] [3] [4] [5] [6] . Importantly, ACLF is often precipitated by bacterial infections, which in turn may initiate a cascade of events resulting in multiple organ failure, irreversible septic shock and death [7, 8] . The reason why the immune system in cirrhosis is defective and patients prone to infections is only partly understood. One reason may be that the immune paralysis observed in cirrhosis is the result of exhaustion of circulating innate immune cells such as monocytes by continuous exposure to, and activation by damageassociated molecular patterns (DAMP's) released from the necrotic liver and from bacterial products translocation from the gut [9,10].
Circulating monocytes are central players in the host innate immune defense against invading pathogens since they can interpret the extent of the microbial threat and raise an appropriate inflammatory response to contain the infection [11, 12] . Following clearance, it is equally important that regulatory mechanisms are initiated to counteract excessive inflammation.
Macrophages for instance are known for their plasticity in adopting either an inflammatory-or regulatory phenotype [13] [14] [15] . During the course of ACLF however, it is unclear whether patients succumb to infection due to a failure of monocytes/macrophages to sufficiently dampen the production of pro-inflammatory mediators leading to septic shock and organ damage, or whether they trigger a prolonged anti-inflammatory response rendering the patient incapable to respond to secondary infections. Nevertheless, studies taking a snap-shot of ACLF monocyte function at a given time, have confirmed the presence of a suppressive monocyte phenotype with reduced HLA-DR surface expression, antigen presentation capacity as well as impaired ability to secrete pro-inflammatory cytokines in response to bacterial components [16] [17] [18] [19] .
Although singular factors such as MerTK or prostaglandin E2 have been implicated as potential mechanisms responsible for monocyte dysfunction during ACLF syndrome [18, 19] , the overarching pathways that drive and sustain these disease-associated defects are not fully understood.
The functional phenotype of monocytes/macrophages is highly regulated at both transcriptional and metabolic levels [20, 21] . To exert their immunological functions, they can metabolize a variety of carbon substrates [22, 23] , and the nature of the metabolic program involved is critically associated with their activation status [24] [25] [26] . For example, pro-inflammatory macrophages consume glucose and heavily rely on glycolysis for ATP generation. Additionally, they exhibit a "broken" tricarboxylic acid (TCA) cycle, allowing accumulation of citrate and succinate. On the other hand, anti-inflammatory monocytes/macrophages maintain an intact TCA cycle and favor fatty acid oxidation, as a mode of ATP production [26] [27] [28] . In this study, the aim was to obtain a comprehensive view of the transcriptional profile of monocytes from ACLF patients and to investigate whether their molecular signature correlated with a functional and metabolic switch towards a suppressive phenotype. More importantly, we investigated whether metabolic rewiring of the cells using pharmacological inhibitors that channel glutamine into the TCA cycle, could restore ACLF monocyte dysfunction. These results may provide new insights into fundamental disease mechanisms.
Materials and methods

Patient characteristics
For this study we recruited healthy controls, decompensated alcoholic cirrhosis, and ACLF patients diagnosed at the University hospital of Leuven between July 2013 to May 2017.
Patients with alcoholic liver disease were identified and prospectively included at first contact in the emergency room (ER), the liver ward or the medical intensive care unit. Patients that used antibiotics or corticosteroid therapy during the 6 weeks preceding admission were not considered for inclusion in the study. Patients with concomitant other liver diseases including viral hepatitis were excluded from participation. Blood was collected for study purposes before initiating other therapy. Blood and urine cultures were obtained, ascites fluid collected for analysis and a chest X-rays performed to exclude infections and pulmonary infiltrates as per standard of care. Patients with ACLF were classified according to the Consortium on Chronic Liver Failure-Sequential Organ Failure Assessment [CLIF-SOFA] classification [4] . Written informed consent was obtained from all patients or their designated family members and the study protocols were approved by the Ethical Commission UZ / KU Leuven (S54588).
Plasma cytokine measurements
Custom Meso Scale Discovery V-plex assays (Gaithersburg, MD) were used to determine plasma cytokine (IL-6, IL-8, IL-10 and TNF and chemokine (CCL2 and CCL3) levels. All measurements were performed in duplicate according to manufactures instructions.
Phenotypic analysis of monocyte subsets and intracellular cytokine determination
Peripheral blood mononuclear cells (PBMCs) were isolated and stained with the following antibodies: CD3, CD19, CD56, CD14, CD16, HLA-DR (eBioscience, San Diego, CA) and matching isotype controls. Flow cytometric data acquisition was performed on a Gallios flow cytometer (Beckman Coulter, Analis, Belgium) and analyzed using FlowJo software [29] . For intracellular staining, PBMCs were stimulated with LPS and brefeldin A (eBioscience), for 18 h and then stained with the same surface antibody cocktail as described above followed by the addition of Cytofix/Cytoperm (eBioscience) and anti-human IL-10 (BD Biosciences, Erembodegem, Belgium).
Monocyte isolation and culture
Blood was collected from healthy donors and ACLF patients in heparin-coated tubes (BD Biosciences). Immediately after collection, CD14 + monocytes were isolated from the PBMC fraction using a negative selection procedure according to the manufacturer's specifications (Dynabeads untouched human Monocyte phagocytic-and oxidative burst capacity following exposure to E. coli
The phagocytic and oxidative burst capacity of human monocytes were assessed as previously described [30] . Briefly, 100 µl heparinized peripheral blood was incubated for 1 hour at 37°C
with pH-rodoRed-labeled E. coli bacteria (Invitrogen), previously opsonized with E. coli
BioParticles®opsonizing reagent (Invitrogen). This was followed by the addition of the fluorogenic substrate rhodamine (20 min at 37°C) and staining for human monocyte markers.
Flow cytometric data acquisition was performed as described above.
RNA isolation and RNA-sequencing analysis
RNA was isolated from freshly isolated monocytes, and from monocytes cultured in the presence or absence of ACLF plasma for 12 hours. RNA quantity and quality was measured, and samples meeting RNA integrity criteria were used for NextGeneration RNA-Sequencing (NGS) analysis using Illumina NextSeq instrument (detailed description in supplements).
Sequencing and initial processing of the raw data was performed by the Nucleomics Core Facility, VIB, Leuven. Sequencing data are available at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE93265.
Data analysis
After preprocessing, reads were aligned to the reference genome of Homo sapiens (GRCh37.73) and a generalized linear model was fitted (described in supplements). In some instances the cells were treated with Methionine sulfoximine at the indicated concentrations. pHrodo® pathogen bioparticles were added at indicated concentrations and the plates were transferred into a humidified incubator (37°C, 5%, CO2) and measured in real time using an IncuCyte Zoom imager (Satorius). Four images per well from three technical replicates were taken every 2 hours using a 10× objective lens and then analyzed using the IncuCyte™ Basic Software.
Real-Time qPCR
cDNA was synthesized using SuperScript II reverse transcriptase and random hexamer primers (Invitrogen/Life Technologies, USA). The PCR reaction was carried out in a mixture that contained appropriate sense-and anti-sense primers and a TaqMan MGB probe in Taq-Man Universal PCR Master Mixture (Applied Biosystems, Foster City, USA). Beta-2-microglobulin was used as housekeeping gene. qRT-PCR amplification and data analysis were performed using the Lightcycler 96 (Roche Applied Science, Penzberg, Germany). Each sample was assayed in duplicate. The ΔΔCq method was used to determine relative gene expression levels.
Statistical analysis
Group comparisons were performed using Kruskal-Wallis with Dunn's correction for multiple testing or Mann-Whitney-Wilcoxon rank sum tests where appropriate. Spearman correlation was used to determine associations between variables. Statistical analyses were performed using JMP® version 11.0.0 (SAS Institute, Inc, Cary, NC) and SigmaPlot 12.0 (Systat Software, Inc., San Jose, USA). Two-sided P-value < 0.05 was considered statistical significant. 
Results
ACLF
ACLF monocytes feature a distinctive immunosuppressive transcriptional profile
To obtain an in-depth understanding of the molecular signatures responsible for this dysfunctional response, we performed a transcriptomic analysis of classical monocytes as the most abundant monocyte subset. CD14 + cells from ACLF patients (n=9), -decompensated cirrhosis patients (n=4) and -healthy controls (n=5) were freshly isolated with a negative selection strategy whereby CD16 + cells were additionally depleted along with all other unwanted cell types to avoid granulocyte contamination (see materials and methods for full description). Notably, ACLF grade 2 patients were included for this purpose to ensure homogeneity within this experimental group whereby the disease status can be very dynamic (see supplemental Table 2 for patient characteristics). Gene Ontology analysis to assess the biological processes involved revealed that the up-regulated genes from decompensated cirrhosis monocytes predominantly associated with immune response or leukocyte activation ( Figure 2A ). Conversely, biological pathways promoting immunological processes and cell activation were associated with the down-regulated genes in ACLF patient monocytes ( Figure   2B ). Although there was an overlap of differentially regulated genes between these two conditions (not shown), the comparison of ACLF monocyte profiles to that of decompensated cirrhosis patients, unveiled unique differences of ACLF as disease entity. In this regard, the immunosuppressive nature in ACLF is further highlighted since the majority of the down regulated genes involve immune response processes ( Figure 2C ).
Focusing specifically on subsets of immune-related genes illustrated that patient-as well as 
Defective antibacterial response of ACLF monocytes
We next aimed to evaluate whether immune dysfunction in ACLF translates into a defective functional capacity of monocytes to detect, engulf and respond to infection. To investigate monocyte ability to detect and recognize bacteria, we evaluated basal surface expression of both TLR2 and TLR4 on classical monocytes from the different patient groups. Interestingly, both decompensated cirrhosis patients as well as ACLF patients portrayed dampened expression levels of these markers ( Figure 3A & 3B). We further assessed the ex vivo phagocytic and oxidative burst capacity of these cells following exposure to E. coli. In line with defective bacterial recognition, monocytes isolated from both decompensated as well as ACLF patients featured a significantly impaired phagocytic capacity, although this defect was most prominent in patients with ACLF ( Figure 3C ). Monocytes from ACLF patients also featured a clear defective oxidative burst response, following interaction with E.coli ( Figure 3D ). To further identify the underlying pathways leading to this functional defect we investigated differentially regulated genes related to the antibacterial and oxidative burst response of monocytes originating from ACLF patients (see schematic representation of the components involved within Figure 3E ). Notably, we detected dampened expression of IRF8, a prominent regulator of monocyte/macrophage pro-inflammatory-and anti-bacterial function. Dampened expression levels of IRF8 may implicate a defective ability to activate transcription of constituents of the NADPH oxidase complex, a key component of the oxidative burst response [33] . Nevertheless, the activity of the subunits within the NADPH oxidase complex can be regulated in different ways including at the level of post-translational modification. In this regard, we observed significantly lower levels of protein kinase C (PRKCE) within ACLF monocytes, suggesting that the defective oxidative burst may be partially related to inadequate phosphorylation of NADPH oxidase subunits. Furthermore, we detected the upregulation of Rnf145, a E3 ubiquitin ligase that negatively regulates gp91phox steady-state protein levels. Combined, our data highlight a number of mechanisms that may explain the functional defect of ACLF patients to respond to-and eradicate infections.
Monocytes cultured with ACLF plasma mimic functional and transcriptional disease characteristics
In order to explore the possibilities of reversing monocyte dysfunction, we devised an ACLF disease-mimicking in vitro model whereby freshly isolated CD14 + monocytes from healthy donors were cultured for 16 hours either in the presence of pooled plasma (20% v/v) from ACLF grade 2 patients or normal human plasma ( Figure 4A ). We first evaluated whether freshly isolated healthy CD14 + monocytes exposed to pooled ACLF grade 2 plasma in vitro, exhibit a transcriptional profile similar to that observed in monocytes obtained from ACLF patients. . We next argued that continued glutamine anabolism through glutamine synthetase (GLUL) may be responsible for the sustained suppressive phenotype of ACLF monocytes and we therefore implemented a strategy to redirect glutamine into the TCA cycle by inhibiting its enzyme activity. Hereto we tested the ability of the inhibitor of glutamine synthetase, methionine sulfoximine (MSO), to restore the phagocytic capacity of ACLF-plasma-conditioned monocytes (the concept thereof can be visualized in Figure 5B ).
Strikingly, treatment of monocytes cultured in the presence of ACLF plasma with MSO triggered a dose-dependent increase in their ability to phagocytose E. coli bioparticles ( Figure   5C ). Considering the importance of the above findings, we reanalyzed the expression levels of parameters involved in glutamine metabolism within ACLF patient monocytes. More specifically, we calculated the ratio of glutamine anabolism over catabolism by assessing GLUL and GLS1 expression levels. Interestingly, the data clearly indicate an elevated GLUL/GLS ratio for monocyte originating from ACLF patients compared to healthy counterparts ( Figure 5D ). To improve our understanding of the significance of these findings, we investigated possible correlations of the GLUL/GLS ratio with survival or MELD scores of the patients. Importantly our data show that the GLUL/GLS ratio positively correlated with disease severity in ACLF patients ( Figure 5E ). Treatment of ACLF patient-derived monocytes with MSO similarly improved their capacity to recognize and engulf bacteria ( Figure 5F ).
Finally, treatment of patient monocytes with MSO inhibited IL-10 production while promoting the production of the pro-inflammatory cytokine, TNFα ( Figure 5G & H) .
Discussion
Bacterial infection is one of the most common precipitating events in ACLF that may initiate In our study we observed that ACLF monocytes displayed profound defects in ex vivo phagocytic and oxidative burst capacity following exposure to E. coli (Fig 3E) that could be recapitulated by exposing healthy monocytes to ACLF plasma (Fig 4G) suggesting a specific defect in anti-bacterial function. We specifically focused on constituents of the Nox2 NADPH oxidase complex, which mediates the generation of reactive oxygen species to kill invading pathogens. Interestingly, although transcription of constituents of the Nox2 NADPH complex
were not severely affected, we observed the upregulation of Rnf145, a negative regulator of the Interestingly, similar immunosuppressive features along with metabolic-and epigenetic reprogramming have been observed in circulating monocytes from late stage sepsis patients [39, 40] . This is in sharp contrast to the characteristic overt upregulation of pro-inflammatory parameters during acute stages of sepsis that resembled more the expression pattern observed in monocytes from decompensated cirrhosis patients [41] . Considering the fact that sepsis is a major cause of death in ACLF patients, future investigations aimed at understanding the mechanisms underlying immune dysfunction, as well as similarities between sepsis-inducedand ACLF-induced immunosuppression, may improve therapeutic strategies [42] . Another In addition to characterizing the full extent of innate immune dysfunction of monocytes from ACLF patients, we highlight a number of possible mechanisms that may explain increased susceptibility to infections. Our data also demonstrates that metabolic programs can be manipulated to rescue defective monocyte phagocytic functions. Finally, this work highlights the importance of metabolic immunotherapeutic strategies in the treatment of ACLF and it will be intriguing for future work to further fine-tune and develop this approach as potential interventional strategy. The results depict the number of pHrodo-positive monocytes over time (C). The GLUL/GLS ratio in monocytes from patients with ACLF compared to monocytes from healthy controls (D).
The correlation of GLUL/GLS ratio with the MELD scores of patients with ACLF (E).
Monocytes obtained ACLF patient were treated with or without MSO and challenged with low doses of pHrodo-labeled E.coli before measuring engulfment with the IncuCyte system (F).
Monocytes obtained from ACLF patients were treated with or without MSO and cultured under normal conditions for 16 hours before assessment of IL-10 (G) and TNFα (H) production. Science, Penzberg, Germany). Each sample was assayed in duplicate. The ΔΔCq method was used to determine relative gene expression levels.
Next Generation Sequencing (NGS) and data processing
NGS was performed on isolated CD14 + cells derived from ACLF patients and healthy controls or from 
Data analysis
To identify the differentially expressed genes between CD14 + cells of ACLF patients compared to healthy controls, unpaired analysis was performed. To identify significantly changed gene expression in isolated CD14 + cells that were cultured in the presence of serum we performed paired analysis. The individual results were combined, the average computed and the resulting p-values of the Limma and EdgeR packages were corrected for multiple testing with Benjamini-Hochberg to control false discovery rate for paired and unpaired analysis (5) . A gene was considered differentially expressed if a 2log fold change >+1 or <-1 and a corrected p < 0.05. We used this in silico analysis to investigate the biological processes and KEGG pathways involved in ACLF. The genes differentially expressed in one direction in patients or after in vitro modulation were used as input in the software packet Webgestalt Quantification of key metabolic parameters from monocytes of healthy donors. Isolated CD14 + monocytes were cultured in the presence or absence of ACLF plasma for 16 hours as described in the methods section. Relative mRNA levels of or metabolic parameters were determined by means of RT-qPCR at the end of the culture period. (Mean ± SEM; n = 6).
